| 1-naphthyl isothiocyanate | multiple interactions | ISO | RGD:1320897 | 6480464 | O(2)-vinyl-1-(pyrrolidin-1-yl)diazen-1-ium-1,2-diolate inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of RIPK1 mRNA] | CTD | PMID:15913567 |
| 1-naphthyl isothiocyanate | increases expression | ISO | RGD:1320897 | 6480464 | 1-Naphthylisothiocyanate results in increased expression of RIPK1 mRNA | CTD | PMID:15913567 |
| 17alpha-ethynylestradiol | increases expression | ISO | RGD:1320897 | 6480464 | Ethinyl Estradiol results in increased expression of RIPK1 mRNA | CTD | PMID:17942748 |
| 17alpha-ethynylestradiol | multiple interactions | ISO | RGD:1320897 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of RIPK1 mRNA | CTD | PMID:17942748 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1320897 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of RIPK1 mRNA | CTD | PMID:12167310 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1320897 | 6480464 | Tetrachlorodibenzodioxin affects the expression of RIPK1 mRNA | CTD | PMID:21570461 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1320897 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of RIPK1 mRNA | CTD | PMID:12167310 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1320897 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of RIPK1 mRNA | CTD | PMID:15800033 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1320897 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of RIPK1 mRNA | CTD | PMID:15800033 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1320897 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of RIPK1 mRNA | CTD | PMID:17942748 |
| 2,4-dinitrotoluene | affects expression | ISO | RGD:1310158 | 6480464 | 2,4-dinitrotoluene affects the expression of RIPK1 mRNA | CTD | PMID:21346803 |
| 2-acetamidofluorene | decreases expression | ISO | RGD:1310158 | 6480464 | 2-Acetylaminofluorene results in decreased expression of RIPK1 mRNA | CTD | PMID:22584684 |
| 4,4'-diaminodiphenylmethane | increases expression | ISO | RGD:1320897 | 6480464 | 4,4'-diaminodiphenylmethane results in increased expression of RIPK1 mRNA | CTD | PMID:18648102 |
| aflatoxin B1 | increases expression | ISO | RGD:1320897 | 6480464 | Aflatoxin B1 results in increased expression of RIPK1 mRNA | CTD | PMID:19770486 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:1320897 | 6480464 | [Benzo(a)pyrene co-treated with XPA gene mutant form co-treated with TRP53 gene mutant form] results in decreased expression of RIPK1 mRNA | CTD | PMID:21715664 |
| benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of RIPK1 mRNA | CTD | PMID:22316170 |
| ceruletide | increases cleavage | ISO | RGD:1310158 | 6480464 | Caerulein results in increased cleavage of RIPK1 protein | CTD | PMID:16339139 |
| cisplatin | increases expression | ISO | RGD:1320897 | 6480464 | Cisplatin results in increased expression of RIPK1 mRNA | CTD | PMID:21151649 |
| cocaine | decreases expression | ISO | RGD:1310158 | 6480464 | Cocaine results in decreased expression of RIPK1 mRNA | CTD | PMID:17898221 |
| copper(2+) sulfate | decreases expression | EXP | | 6480464 | Copper Sulfate results in decreased expression of RIPK1 mRNA | CTD | PMID:19549813 |
| diarsenic trioxide | increases cleavage | EXP | | 6480464 | arsenic trioxide results in increased cleavage of RIPK1 protein | CTD | PMID:15314284 |
| dibutyl phthalate | increases expression | ISO | RGD:1320897 | 6480464 | Dibutyl Phthalate results in increased expression of RIPK1 mRNA | CTD | PMID:21266533 |
| furosemide | affects expression | ISO | RGD:1310158 | 6480464 | Furosemide affects the expression of RIPK1 mRNA | CTD | PMID:17497460 |
| hydralazine | multiple interactions | EXP | | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of RIPK1 mRNA | CTD | PMID:17183730 |
| mangiferin | decreases expression | ISO | RGD:1320897 | 6480464 | mangiferin results in decreased expression of RIPK1 mRNA | CTD | PMID:15135318 |
| methapyrilene | decreases expression | ISO | RGD:1310158 | 6480464 | Methapyrilene results in decreased expression of RIPK1 mRNA | CTD | PMID:22584684 |
| resveratrol | decreases expression | ISO | RGD:1320897 | 6480464 | resveratrol analog results in decreased expression of RIPK1 protein | CTD | PMID:15652768 |
| trans-resveratrol | decreases expression | ISO | RGD:1320897 | 6480464 | resveratrol analog results in decreased expression of RIPK1 protein | CTD | PMID:15652768 |
| ursodeoxycholic acid | multiple interactions | EXP | | 6480464 | RIPK1 mutant form inhibits the reaction [Ursodeoxycholic Acid results in increased cleavage of CASP3 protein]; more ... | CTD | PMID:21362627 |
| valproic acid | affects expression | ISO | RGD:1320897 | 6480464 | Valproic Acid affects the expression of RIPK1 mRNA | CTD | PMID:17963808 |
| valproic acid | multiple interactions | EXP | | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of RIPK1 mRNA | CTD | PMID:17183730 |
| valproic acid | decreases expression | ISO | RGD:1320897 | 6480464 | Valproic Acid results in decreased expression of RIPK1 mRNA | CTD | PMID:21427059 |